SEC Form 4 · accession 0001562180-19-001481
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Silji Abraham
Officer — Chief Digital & Trans Officer
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 3:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | F | 473 | $103.77 | D | 4,165 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld solely for the purpose of satisfying tax liability due upon vesting of restricted stock award.